Clip From
Created by an anonymous user on November 15, 2013

Rep. Engel questions FDA's Dr. Janet Woodcock

Mentions rare disease, accelerated approval, Duchenne muscular dystrophy; Sarepta Therapeutics & eteplirsen, patient advocacy, establishing natural history of rare diseases

Video Library clips and descriptions are created by MyC-SPAN users, and are not the editorial selections of C-SPAN.

Report profane or abusive content

*The transcript for this program was compiled from uncorrected Closed Captioning.

People in this video

  • Eliot Engel U.S. Representative [D] New York
  • Janet Woodcock M.D. Director U.S. Food and Drug Administration->Center for Drug Evaluation and Research

Hosting Organization

More Videos From

House Energy & Commerce Committee: Implementation of FDA Safety & Innovation Act

More information about

Rep. Engel questions FDA's Dr. Janet Woodcock

40 Views
Program ID:
316262-2
Category:
House Committee
Format:
House Committee
Location:
Washington, District of Columbia, United States
Purchase a DVD or Download

Rep. Engel questions FDA's Dr. Janet Woodcock

  • MP4 video - Standard
    Request Download
  • MP4 video - Low
    Request Download
  • MP3 audio
    Request Download

Clips from This Video